Shionogi & Co. Ltd.

In News

Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd. - PR Newswire

PR Newswire - Feb 10, 2026

Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership - Yahoo Finance

Yahoo Finance - Jan 25, 2026

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 12-Month High - Still a Buy? - MarketBeat

MarketBeat - Feb 10, 2026

Shionogi Invests $2.1 Billion to Raise ViiV Healthcare Stake - Bloomberg.com

Bloomberg.com - Jan 20, 2026

Shionogi to buy Jersey City pharma for $2.5B - NJBIZ

NJBIZ - Dec 23, 2025

ALS med Radicava to change hands as Shionogi inks $2.5B buyout - Fierce Pharma

Fierce Pharma - Dec 22, 2025

Pfizer to exit ViiV Healthcare in $1.9 billion deal as Shionogi doubles stake - Reuters

Reuters - Jan 20, 2026

The Power to Create Medicines That Reach Patients—Passing SHIONOGI’s Baton of Innovation to the Next Generation - Shionogi Inc.

Shionogi Inc. - Oct 09, 2025

Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up - Pharmaceutical Technology

Pharmaceutical Technology - Jan 20, 2026

Shionogi Increasing Stake in ViiV Healthcare for $2.1 Bn; Pfizer Exits the HIV JV - DCAT Value Chain Insights

DCAT Value Chain Insights - Jan 22, 2026

FDA Accepts Shionogi’s NDA for Ensitrelvir Oral Antiviral in COVID-19 Postexposure Prevention - Contagion Live

Contagion Live - Sep 02, 2025

Pfizer sells its stake in GSK's ViiV for $1.9B, with Shionogi upping its ante in the HIV-focused company - Fierce Pharma

Fierce Pharma - Jan 20, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment